1887

Abstract

Gamma interferon (IFN-) plays a major role in the protection against lethal infection with mouse hepatitis virus A59. IFN- production reaches a maximum level 2 days after viral inoculation, especially in liver immune cells. Among these cells, natural killer cells are the major producers of this cytokine. Transfer experiments indicated that the protective role of IFN- is mediated through a direct effect on cells targeted by the virus rather than through indirect activation of T lymphocytes.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.005876-0
2009-02-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/2/442.html?itemId=/content/journal/jgv/10.1099/vir.0.005876-0&mimeType=html&fmt=ahah

References

  1. Barthold S. W., Smith A. L. 2007; Mouse hepatitis virus. In The Mouse in Biomedical Research . , 2nd edn. vol. 2, Diseases pp 141–178Edited by Fox J. G., Barthold S. W., Davisson M. T., Newcomer C. E., Quimby F. W., Smith. Burlington, San Diego, London: Academic Press;
  2. Bergmann C. C., Parra B., Hinton D. R., Ramakrishna C., Dowdell K. C., Stohlman S. A. 2004; Perforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells. J Virol 78:1739–1750 [CrossRef]
    [Google Scholar]
  3. Bukowski J. F., Woda B. A., Habu S., Okumura K., Welsh R. M. 1983; Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo . J Immunol 131:1531–1538
    [Google Scholar]
  4. Coulie P. G., Coutelier J.-P., Uyttenhove C., Lambotte P., Van Snick J. 1985; In vivo suppression of T-dependent antibody responses by treatment with a monoclonal anti-L3T4 antibody. Eur J Immunol 15:638–640 [CrossRef]
    [Google Scholar]
  5. Coutelier J.-P. 1991; Enhancement of IgG production elicited in mice by treatment with anti-CD8 antibody. Eur J Immunol 21:2617–2620 [CrossRef]
    [Google Scholar]
  6. Daniels K. A., Devora G., Lai W. C., O'Donnell C. L., Bennett M., Welsh R. M. 2001; Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med 194:29–44 [CrossRef]
    [Google Scholar]
  7. Dialynas D. P., Wilde D. B., Marrack P., Pierres A., Wall K. A., Havran W., Otten G., Loken M. R., Pierres M. other authors 1983; Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II antigen-reactivity. Immunol Rev 74:29–56 [CrossRef]
    [Google Scholar]
  8. El Azami El Idrissi M., Mazza G., Monteyne P., Elson C. J., Day M. J., Pfau C. J., Coutelier J.-P. 1998; Lymphocytic choriomeningitis virus-induced alterations of T helper-mediated responses in mice developing autoimmune hemolytic anemia during the course of infection. Proc Soc Exp Biol Med 218:349–356 [CrossRef]
    [Google Scholar]
  9. Godfraind C., Coutelier J.-P. 1998; Morphological analysis of mouse hepatitis virus A59-induced pathology with regard to viral receptor expression. Histol Histopathol 13:181–199
    [Google Scholar]
  10. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R. M., Aguet M. 1993; Immune response in mice that lack the interferon- γ receptor. Science 259:1742–1745 [CrossRef]
    [Google Scholar]
  11. Kiessling R., Hochman P. S., Haller O., Shearer G. M., Wigzell H., Cudkowicz G. 1977; Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol 7:655–663 [CrossRef]
    [Google Scholar]
  12. Kyuwa S., Machii K., Shibata S. 1996; Role of CD4+ and CD8+ T cells in mouse hepatitis virus infection in mice. Exp Anim 45:81–83 [CrossRef]
    [Google Scholar]
  13. Kyuwa S., Tagawa Y., Machii K., Shibata S., Doi K., Fujiwara K., Iwakura Y. 1998; MHV-induced fatal peritonitis in mice lacking IFN- γ . Adv Exp Med Biol 440:445–450
    [Google Scholar]
  14. Kyuwa S., Shibata S., Tagawa Y., Iwakura Y., Machii K., Urano T. 2002; Acute hepatic failure in IFN- γ -deficient BALB/c mice after murine coronavirus infection. Virus Res 83:169–177 [CrossRef]
    [Google Scholar]
  15. Lamontagne L., Lusignan S., Page C. 2001; Recovery from mouse hepatitis virus infection depends on recruitment of CD8+ cells rather than activation of intrahepatic CD4+ αβ TCRinter or NK-T cells. Clin Immunol 101:345–356 [CrossRef]
    [Google Scholar]
  16. Ledbetter J. A., Herzenberg L. A. 1979; Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 47:63–90 [CrossRef]
    [Google Scholar]
  17. Lehoux M., Jacques A., Lusignan S., Lamontagne L. 2004; Murine viral hepatitis involves NK cell depletion associated with virus-induced apoptosis. Clin Exp Immunol 137:41–51 [CrossRef]
    [Google Scholar]
  18. Loh J., Chu D. T., O'Guin A. K., Yokoyama W. M., Virgin H. W. IV 2005; Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol 79:661–667 [CrossRef]
    [Google Scholar]
  19. Lotzova E., Savary C. A., Pollack S. B. 1983; Prevention of rejection of allogeneic bone marrow transplants by NK 1.1 antiserum. Transplantation 35:490–494 [CrossRef]
    [Google Scholar]
  20. Lucchiari M. A., Martin J. P., Modolell M., Pereira C. A. 1991; Acquired immunity of A/J mice to mouse hepatitis virus 3 infection: dependence on interferon- γ synthesis and macrophage sensitivity to interferon- γ . J Gen Virol 72:1317–1322 [CrossRef]
    [Google Scholar]
  21. Markine-Goriaynoff D., Hulhoven X., Cambiaso C. L., Monteyne P., Briet T., Gonzalez M.-D., Coulie P., Coutelier J.-P. 2002; Natural killer cell activation after infection with lactate dehydrogenase-elevating virus. J Gen Virol 83:2709–2716
    [Google Scholar]
  22. Pearce B. D., Hobbs M. V., McGraw T. S., Buchmeier M. J. 1994; Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J Virol 68:5483–5495
    [Google Scholar]
  23. Pellicci D. G., Hammond K. J., Coquet J., Kyparissoudis K., Brooks A. G., Kedzierska K., Keating R., Turner S., Berzins S. other authors 2005; DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells. J Immunol 175:4416–4425 [CrossRef]
    [Google Scholar]
  24. Schijns V. E. C. J., Wierda C. M. H., van Hoeij M., Horzinek M. C. 1996; Exacerbated viral hepatitis in IFN- γ receptor-deficient mice is not suppressed by IL-12. J Immunol 157:815–821
    [Google Scholar]
  25. Schijns V. E. C. J., Haagmans B. L., Wierda C. M. H., Kruithof B., Heijnen I. A. F. M., Alber G., Horzinek M. C. 1998; Mice lacking IL-12 develop polarized Th1 cells during viral infection. J Immunol 160:3958–3964
    [Google Scholar]
  26. Smith A. L., Barthold S. W., de Souza M. S., Bottomly K. 1991; The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM. Arch Virol 121:89–100 [CrossRef]
    [Google Scholar]
  27. Sutherland R. M., Chua M.-M., Lavi E., Weiss S. R., Paterson Y. 1997; CD4+ and CD8+ T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. J Neurovirol 3:225–228 [CrossRef]
    [Google Scholar]
  28. Templeton S. P., Perlman S. 2008; Role of IFN- γ responsiveness in CD8 T cell-mediated viral clearance and demyelination in coronavirus-infected mice. J Neuroimmunol 194:18–26 [CrossRef]
    [Google Scholar]
  29. Trifilo M. J., Montalto-Morrison C., Stiles L. N., Hurst K. R., Hardison J. L., Manning J. E., Masters P. S., Lane T. E. 2004; CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. J Virol 78:585–594 [CrossRef]
    [Google Scholar]
  30. Walsh K. B., Lodoen M. B., Edwards R. A., Lanier L. L., Lane T. E. 2008; Evidence for differential roles for NKG2D receptor signaling in innate host defense against coronavirus-induced neurological and liver disease. J Virol 82:3021–3030 [CrossRef]
    [Google Scholar]
  31. Wieland S. F., Vega R. G., Müller R., Evans C. F., Hilbush B., Guidotti L. G., Sutcliffe J. G., Schultz P. G., Chisari F. V. 2003; Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol 77:1227–1236 [CrossRef]
    [Google Scholar]
  32. Wijburg O. L. C., Heemskerk M. H. M., Sanders A., Boog C. J. P., Van Rooijen N. 1996; Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection. Immunology 87:34–41
    [Google Scholar]
  33. Williamson J. S. P., Stohlman S. A. 1990; Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ cells. J Virol 64:4589–4592
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.005876-0
Loading
/content/journal/jgv/10.1099/vir.0.005876-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error